About Quantalife
Quantalife is a company based in Pleasanton (United States) founded in 2008 was acquired by Bio Rad in October 2011. Quantalife has raised $28.71 million across 3 funding rounds from investors including Bio Rad, Paladin Capital and Vital Venture Capital. Quantalife operates in a competitive market with competitors including Stilla Technologies, NeuMoDx, Souzhou Ribo Life Science, Kryptos Biotechnologies and Altratech, among others.
- Headquarter Pleasanton, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Quantalife, Inc
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Quantalife
Quantalife has successfully raised a total of $28.71M across 3 strategic funding rounds. The most recent funding activity was a Series B round of $3.56 million completed in July 2011. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Quantalife
Quantalife has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include Bio Rad, Paladin Capital and Vital Venture Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital is invested in multiple sectors by Paladin Capital.
|
Locked | Locked | Locked | |
|
Private investments are made in early and later-stage businesses.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for Quantalife
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Quantalife
Investment portfolio details for Quantalife
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Quantalife
Detailed financials for Quantalife
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Quantalife Comparisons
Peer comparison for Quantalife
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Quantalife
Quantalife operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Stilla Technologies, NeuMoDx, Souzhou Ribo Life Science, Kryptos Biotechnologies and Altratech, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Digital PCR solutions for research are developed and analyzed.
|
|
| Locked | Locked | Locked |
Developer of a platform for low cost molecular testing
|
|
| Locked | Locked | Locked |
Nucleic acid drugs are developed via RNA interference technology.
|
|
| Locked | Locked | Locked |
Point-of-care molecular diagnostics are enabled by Ultrafast Photonic PCR technology.
|
|
| Locked | Locked | Locked |
Next-generation molecular detection kits for viral diseases are developed.
|
|
| Locked | Locked | Locked |
Point-of-care diagnostic devices for infectious diseases are developed.
|
Detailed competitors of Quantalife
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Quantalife
Complete news archive for Quantalife
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Quantalife
Quantalife was founded in 2008 and raised its 1st funding round 1 year after it was founded.
Quantalife is headquartered in Pleasanton, United States. It is registered at Pleasanton, California, United States.
Quantalife is a funded company, having raised a total of $28.71M across 3 funding rounds to date.
QuantaLife provides tools that accelerate new strategies for the diagnosis and treatment of inherited disorders, cancer, and infectious disease. It developed Droplet Digital PCR. Droplet Digital PCR provides an absolute measure of target molecules with unrivaled quantitative resolution and sensitivity. Applications include copy number variation (CNV), mutation detection, and gene expression analysis. Now this technology is part of Bio-rad as QuantaLife was acquired by Bio-rad in Oct, 2011.
Quantalife's top competitors include Stilla Technologies, NeuMoDx and Souzhou Ribo Life Science.
Quantalife has 4 investors. Key investors include Bio Rad, Paladin Capital, Vital Venture Capital, and Merieux Developement.